Regenlab USA plans IPO of 2.5 million common shares
Regenlab USA said in an SEC filing that it plans an initial public offering of 2.5 million common shares. The expected price range is $6 to $8 per share.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Regenlab USA, according to Reuters, disclosed in a filing with the SEC that it intends to hold an initial public offering of 2.5 million common shares.
The filing puts the expected price range for the offering between $6 and $8 per share.
why it matters
Offerings of this size from small companies typically draw attention from a narrow group of investors. The final IPO price will show how the market values the business, but for the broader market this is a second-tier story.
tags
instruments
sources
- Regenlab USA Sees IPO Of 2.5 Mln Common Stock Shares — Reuters, 27 October 2026 at 18:33 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗